文献速递心力衰竭与心肌病

心力衰竭中细胞外基质:ADAMTS5在蛋白聚糖重塑中的作用

Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling.
PubMed 文献 · Circulation · 2021-11-22

该研究探讨ADAMTS5及其底物versican在心力衰竭中的作用。在缺乏ADAMTS5催化结构域的小鼠中,血管紧张素II输注导致versican积聚和心脏功能受损。对缺血性心衰患者心脏样本的蛋白质组学分析显示,使用β受体阻滞剂与细胞外基质沉积减少相关,versican变化最显著。

要点

  • ADAMTS5介导的versican降解对维持心脏功能至关重要
  • β受体阻滞剂可能减少缺血性心衰患者心脏versican沉积
  • versican积聚与心脏功能受损相关

核心结论

  • ADAMTS蛋白酶对心脏versican降解至关重要,versican积聚与心脏功能受损相关。
  • β受体阻滞剂可能对缺血性心衰患者心脏硫酸软骨素蛋白聚糖含量有未认识的有益影响。

研究设计与样本

  • 研究使用缺乏ADAMTS5催化结构域的小鼠(Adamts5ΔCat)以及缺血性心衰患者左心室样本(n=65)进行蛋白质组学分析。
  • 还在猪心脏缺血/再灌注损伤模型和血管紧张素II输注小鼠中评估versikine水平。

主要发现

  • 在缺血性心衰患者中,versican和versikine(ADAMTS特异性versican裂解产物)积累。
  • 在猪心脏缺血/再灌注损伤模型和血管紧张素II输注小鼠中,versikine也升高。
  • 在Adamts5ΔCat小鼠中,血管紧张素II输注导致versican积聚加重和透明质酸排列紊乱,伴随整合素β1、细丝蛋白A和连接蛋白43水平降低。
  • 超声心动图评估显示Adamts5ΔCat小鼠在血管紧张素II输注后射血分数降低和整体纵向应变受损,而心脏肥厚和胶原沉积与野生型对照相似。
  • 在缺血性心衰患者心脏外植体(n=65)的蛋白质组学分析中,使用β受体阻滞剂与细胞外基质沉积减少相关,versican是变化最显著的蛋白之一。

临床怎么用

  • β受体阻滞剂可能通过减少versican沉积改善缺血性心衰患者的心脏细胞外基质重塑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Remodeling of the extracellular matrix (ECM) is a hallmark of heart failure (HF). Our previous analysis of the secretome of murine cardiac fibroblasts returned ADAMTS5 (a disintegrin and metalloproteinase with thrombospondin motifs 5) as one of the most abundant proteases. ADAMTS5 cleaves chondroitin sulfate proteoglycans such as versican. The contribution of ADAMTS5 and its substrate versican to HF is unknown. METHODS: Versican remodeling was assessed in mice lacking the catalytic domain of ADAMTS5 (Adamts5ΔCat). Proteomics was applied to study ECM remodeling in left ventricular samples from patients with HF, with a particular focus on the effects of common medications used for the treatment of HF. RESULTS: Versican and versikine, an ADAMTS-specific versican cleavage product, accumulated in patients with ischemic HF. Versikine was also elevated in a porcine model of cardiac ischemia/reperfusion injury and in murine hearts after angiotensin II infusion. In Adamts5ΔCat mice, angiotensin II infusion resulted in an aggravated versican build-up and hyaluronic acid disarrangement, accompanied by reduced levels of integrin β1, filamin A, and connexin 43. Echocardiographic assessment of Adamts5ΔCat mice revealed a reduced ejection fraction and an impaired global longitudinal strain on angiotensin II infusion. Cardiac hypertrophy and collagen deposition were similar to littermate controls. In a proteomics analysis of a larger cohort of cardiac explants from patients with ischemic HF (n=65), the use of β-blockers was associated with a reduction in ECM deposition, with versican being among the most pronounced changes. Subsequent experiments in cardiac fibroblasts confirmed that β1-adrenergic receptor stimulation increased versican expression. Despite similar clinical characteristics, patients with HF treated with β-blockers had a distinct cardiac ECM profile. CONCLUSIONS: Our results in animal models and patients suggest that ADAMTS proteases are critical for versican degradation in the heart and that versican accumulation is associated with impaired cardiac function. A comprehensive characterization of the cardiac ECM in patients with ischemic HF revealed that β-blockers may have a previously unrecognized beneficial effect on cardiac chondroitin sulfate proteoglycan content.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Barallobre-Barreiro, Radovits, Fava, et al. Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling. Circulation. 2021. PMID: 34806902. doi:10.1161/CIRCULATIONAHA.121.055732

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。